PHARMACOECONOMIC ANALYSIS OF AXITINIB AS SECOND-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA

被引：0
|
作者：
Kulikov, A. [1 ]
Komarov, I [1 ]
机构：
[1] First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2299
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN141
引用
收藏
页码：A638 / A639
页数：2
相关论文
共 50 条
  • [21] ECONOMIC EVALUATION OF EVEROLIMUS AS SECOND-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN GREECE
    Solakidi, A.
    Kourlaba, G.
    Kontovinis, L.
    Koutsoukos, K.
    Bournakis, E.
    Boutis, A.
    Syrios, J.
    Tzovaras, A.
    Michailidi, C.
    Kalogeropoulou, M.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A732 - A732
  • [22] Sorafenib as second-line treatment in metastatic renal cell carcinoma: A prospective cohort.
    Martin Aguilar, Ana Elena
    Nayeli Nunez-Lopez, Haide
    Carlos Ramirez-Sandoval, Juan C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy
    Guida, Annalisa
    Albiges, Laurence
    Derosa, Lisa
    Loriot, Yohann
    Massard, Christophe
    Fizazi, Karim
    Escudier, Bernard
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E1081 - E1088
  • [24] Axitinib for the treatment of metastatic renal cell carcinoma
    Parekh, Hiral
    Griswold, Julianne
    Rini, Brian
    [J]. FUTURE ONCOLOGY, 2016, 12 (03) : 303 - 311
  • [25] Axitinib in the treatment of metastatic renal cell carcinoma
    Ho, Thai H.
    Jonasch, Eric
    [J]. FUTURE ONCOLOGY, 2011, 7 (11) : 1247 - 1253
  • [26] Phase III AXIS trial for second-line metastatic renal cell carcinoma (mRCC): Effect of prior first-line treatment duration and axitinib dose titration on axitinib efficacy.
    Rini, Brian I.
    Escudier, Bernard J.
    Michaelson, M. Dror
    Negrier, Sylvie
    Gore, Martin Eric
    Oudard, Stephane
    Clark, Joseph
    Tarazi, Jamal Christo
    Rosbrook, Brad
    Kim, Sinil
    Motzer, Robert John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [27] The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma
    Kameda, Tomohiro
    Takayama, Tatsuya
    Sugihara, Toru
    Takeshima, Saki
    Yamazaki, Masahiro
    Komatsubara, Maiko
    Kamei, Jun
    Fujisaki, Akira
    Ando, Satoshi
    Kurokawa, Shinsuke
    Fujimura, Tetsuya
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (04) : 241 - 246
  • [28] Second-line treatment of metastatic prostatic carcinoma
    Newling, DWW
    [J]. UROLOGICAL RESEARCH, 1997, 25 (Suppl 2): : S73 - S78
  • [29] Second-line treatment of metastatic prostatic carcinoma
    D. W. W. Newling
    [J]. Urological Research, 1997, 25 : S73 - S78
  • [30] CLINICAL EFFECTIVENESS AND COST-EFFECTIVE SECOND-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA
    Romero, M.
    Diaz, E.
    Malagon, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A543 - A543
12345